Arbuckle Stuart A sold VRTX
May 15, 2024 · Form 4 insider transaction
Arbuckle Stuart A sold 69 shares of Vertex Pharmaceuticals Incorporated at $430.93 per share, a transaction worth $29.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
69
Price
$430.93
Total value
$29.7K
InsiderArbuckle Stuart A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 15, 2024
Filing dateMay 17, 2024
Shares owned after49,691
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.